MedEngine, founded with a mission to improve the lives of people with Parkinson's disease, leverages wearable medical technology to enhance patient-centric care. Their flagship product, Flytta, is an app designed to capture both motor and non-motor symptoms, aiding in more effective and safer self-management for patients. MedEngine aims to empower patients with the information needed to actively participate in their care decisions, thus re-balancing the Parkinson's care ecosystem.
Notable figures affiliated with MedEngine include Philipp Brunnbauer, who can be contacted for more information about the company and its products. MedEngine has made significant strides in the healthcare sector by providing innovative solutions that improve patient outcomes and engagement. Their impact is evident in the enhanced quality of life for Parkinson's patients who use Flytta, marking a significant achievement in the realm of wearable medical technology.
